Harnessing Generative AI for Clinical Trial Documentation White Paper

Harnessing Generative AI for Clinical Trial Documentation

This white paper delves into the transformative potential of large language models (LLMs) and generative AI based on LLMs in streamlining clinical and regulatory documentation processes. It critically examines both the capabilities and limitations of these advanced tools, providing a balanced view that moves beyond the initial excitement surrounding AI.

In this paper you will learn: 

• The capabilities and limitations of LLMs 
• The evolving role of medical writers in the context of technological advancements 
• Specific areas in which LLMs can add significant value to clinical trial documentation processes 
• Recommendations for and insights into the future of generative AI integration into clinical documentation workflows